• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二甲胺在人体中的代谢情况。

Fate of dimethylamine in man.

作者信息

Zhang A Q, Mitchell S C, Barrett T, Ayesh R, Smith R L

机构信息

Department of Pharmacology and Toxicology, St Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London, UK.

出版信息

Xenobiotica. 1994 Apr;24(4):379-87. doi: 10.3109/00498259409045901.

DOI:10.3109/00498259409045901
PMID:8059541
Abstract
  1. The fate of [14C]-dimethylamine was investigated following oral administration to four male volunteers. 2. The major route of excretion was urine, with 94% of the administered radioactivity being voided over 3 days (87% during the first 24 h). Small amounts (1-3%) of radioactivity were found in the faeces and expired air. 3. Metabolism was limited with only 5% being demethylated to methylamine. The remainder of the dose was excreted unchanged. 4. Pharmacokinetic studies indicated rapid (t1/2ab = 8 min) and extensive absorption (bioavailability = 82%) from the gastrointestinal tract followed by widespread distribution and a fairly prompt excretion (t1/2el = 6-7 h) with a plasma clearance of 190 ml/min.
摘要
  1. 对四名男性志愿者口服给予[14C]-二甲胺后,研究了其代谢情况。2. 排泄的主要途径是尿液,给药放射性的94%在3天内排出(头24小时内排出87%)。在粪便和呼出气体中发现少量(1 - 3%)放射性。3. 代谢有限,仅有5%被脱甲基生成甲胺。其余剂量以原形排出。4. 药代动力学研究表明,胃肠道吸收迅速(吸收半衰期t1/2ab = 8分钟)且广泛(生物利用度 = 82%),随后广泛分布,并相当迅速地排泄(消除半衰期t1/2el = 6 - 7小时),血浆清除率为190毫升/分钟。

相似文献

1
Fate of dimethylamine in man.二甲胺在人体中的代谢情况。
Xenobiotica. 1994 Apr;24(4):379-87. doi: 10.3109/00498259409045901.
2
Fate of dimethylamine in rat and mouse.二甲胺在大鼠和小鼠体内的代谢情况
Xenobiotica. 1994 Dec;24(12):1215-21. doi: 10.3109/00498259409038677.
3
Metabolic disposition of [14C]-trimethylamine N-oxide in rat: variation with dose and route of administration.
Xenobiotica. 1997 Nov;27(11):1187-97. doi: 10.1080/004982597239949.
4
Pharmacokinetics and biotransformation of the anxiolytic abecarnil in healthy volunteers.抗焦虑药阿贝卡尼在健康志愿者体内的药代动力学及生物转化
Xenobiotica. 1991 Jun;21(6):763-74. doi: 10.3109/00498259109039516.
5
Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.硫酸氨基葡萄糖的吸收、分布、代谢及排泄。综述
Arzneimittelforschung. 2001 Sep;51(9):699-725. doi: 10.1055/s-0031-1300105.
6
Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.乙二醇的药代动力学。III. 雄性Sprague-Dawley大鼠单次递增静脉注射、口服或经皮给药后的血浆处置及代谢转归
Xenobiotica. 1996 May;26(5):515-39. doi: 10.3109/00498259609046729.
7
Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.新型降胆固醇化合物S-8921在大鼠和犬体内的处置与代谢
Arzneimittelforschung. 1998 Oct;48(10):995-1006.
8
Pharmacokinetics and metabolism of ethylenediamine in the swiss webster mouse following oral or intravenous dosing.
Toxicol Lett. 2000 Sep 30;117(1-2):107-14. doi: 10.1016/s0378-4274(00)00252-6.
9
Metabolism and disposition of [(14)C]dimethylamine borane in male Harlan Sprague Dawley rats following gavage administration, intravenous administration and dermal application.经口灌胃、静脉注射和皮肤涂抹给予雄性哈兰·斯普拉格·道利大鼠[(14)C]二甲胺硼烷后的代谢与处置情况。
Xenobiotica. 2014 Jan;44(1):36-47. doi: 10.3109/00498254.2013.800662. Epub 2013 Jun 20.
10
Absorption, Metabolism, Excretion, and the Contribution of Intestinal Metabolism to the Oral Disposition of [14C]Cobimetinib, a MEK Inhibitor, in Humans.MEK抑制剂[14C]考比替尼在人体内的吸收、代谢、排泄以及肠道代谢对其口服处置的贡献。
Drug Metab Dispos. 2016 Jan;44(1):28-39. doi: 10.1124/dmd.115.066282. Epub 2015 Oct 8.

引用本文的文献

1
Dimethylamine enhances platelet hyperactivity in chronic kidney disease model.二甲胺增强慢性肾病模型中的血小板高反应性。
J Bioenerg Biomembr. 2021 Oct;53(5):585-595. doi: 10.1007/s10863-021-09913-4. Epub 2021 Jul 30.
2
Urinary Dimethylamine (DMA) and Its Precursor Asymmetric Dimethylarginine (ADMA) in Clinical Medicine, in the Context of Nitric Oxide (NO) and Beyond.临床医学中尿二甲基胺(DMA)及其前体不对称二甲基精氨酸(ADMA):一氧化氮(NO)背景及其他
J Clin Med. 2020 Jun 12;9(6):1843. doi: 10.3390/jcm9061843.